172@29@16@58!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=1&is_responsive=1&sec=&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
you are here:

Brooks Laboratories Ltd.

BSE: 533543 | NSE: BROOKS |

Shares falling in the `Trade-to-Trade` or `T-segment` are traded in this series and no intraday is allowed. This means trades can only be settled by accepting or giving the delivery of shares.
Series: BE | ISIN: INE650L01011 | SECTOR: Pharmaceuticals

BSE Live

Oct 23, 16:00
56.35 -1.40 (-2.42%)
Volume
AVERAGE VOLUME
5-Day
8,026
10-Day
13,381
30-Day
20,844
4,544
  • Prev. Close

    57.75

  • Open Price

    58.55

55.10

Today’s L/H

58.55
14.05

52 Wk L/H

72.25
54.90

L/U Price Band

60.60
  • Bid Price (Qty.)

    56.45 (158)

  • Offer Price (Qty.)

    57.05 (42)

  •  VWAP

    56.48
     Beta
    0.42
  • Market Depth (23 Oct 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    158 56.45 57.00 5
    100 56.40 57.05 42
    1 56.35 57.50 200
    241 56.10 57.60 100
    100 56.05 57.75 100
    971 Total Total 2484
     Market Depth
    BUY 971.00
    SELL 2484.00
    28%
    72%

NSE Live

Oct 23, 15:50
56.90 -0.65 (-1.13%)
Volume
AVERAGE VOLUME
5-Day
18,959
10-Day
24,613
30-Day
59,096
6,940
  • Prev. Close

    57.55

  • Open Price

    57.90

56.00

Today’s L/H

58.00
13.85

52 Wk L/H

72.00
54.70

L/U Price Band

60.40
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    56.90 (49)

  •  VWAP

    57.09
     Beta
    0.40
  • DELIVERY AVERAGES
    3-Day
    56.13%
    5-Day
    58.17%
    8-Day
    60.28%
    Deliverables
  • SMA
    30
    57.65
    50
    50.65
    150
    35.98
    200
    34.16
    SMA
    57.65
Powered by Trendlyne

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Neutral
Moving Averages Neutral
Technical Indicators Neutral
Moving Averages Crossovers Neutral
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 57.93 58.97 59.93 56.97 55.93 54.97 53.93
Fibonacci 57.73 58.20 58.97 56.97 56.20 55.73 54.97
Camarilla 57.08 57.27 57.45 56.97 56.72 56.53 56.35

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 58.79
10 59.32
20 62.30
50 50.65
100 41.22
200 34.16
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels

Type R1 R2 R3 PP S1 S2 S3
Classic 65.77 70.38 75.77 60.38 55.77 50.38 45.77
Fibonacci 64.20 66.56 70.38 60.38 56.56 54.20 50.38
Camarilla 62.07 62.98 63.90 60.38 60.23 59.32 58.40

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 79.43 93.67 115.33 57.77 43.53 21.87 7.63
Fibonacci 71.48 79.95 93.67 57.77 44.05 35.58 21.87
Camarilla 68.49 71.78 75.07 57.77 61.91 58.62 55.33

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Valuation

    • Market Cap (Rs Cr.)
      139.20
    • P/E
      -
    • Book Value (Rs)
      46.87
    • Dividend (%)
      -
    • Market Lot
      1
    • Industry P/E
      36.59
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      1.20
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      10.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      56.13
      5-Day
      58.17
      8-Day
      60.28
      54.83

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      139.20
    • P/E
      -
    • Book Value (Rs)
      -
    • Dividend (%)
      -
    • Market Lot
      1
    • Industry P/E
      36.59
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      -
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      -
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      56.13
      5-Day
      58.17
      8-Day
      60.28
      54.83

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Forum

Community Sentiments

  • 100% BUY
  • 0% SELL
  • 0% HOLD
100%
of moneycontrol users recommend buying Brooks Labs

What's your call on Brooks Labs today?

Read 0 investor views

BUY SELL HOLD

Action in Brooks Laboratories Ltd.

  • Technicals

    Brooks Labs closes below 30-Day Moving Average of 57.05 today.

    Oct 23

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Oct 14, 14:10

  • Only Sellers

    Only Sellers in Brooks Labs on NSE

    Oct 12, 11:15

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Oct 06, 10:40

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Oct 05, 10:40

  • Only Sellers

    Only Sellers in Brooks Labs on NSE

    Oct 01, 10:05

  • Only Sellers

    Only Sellers in Brooks Labs on NSE

    Sep 30, 12:45

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Sep 30, 10:05

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Sep 29, 10:05

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Sep 28, 10:05

  • AGM/EGM

    Brooks Labs AGM on Sep 28, 2020, Announcement date: Sep 04, 2020

    Sep 27, 11:00

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Sep 25, 10:05

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Sep 24, 10:05

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Sep 23, 10:05

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Sep 21, 10:05

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Sep 18, 10:05

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Sep 17, 11:20

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Sep 16, 10:05

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Sep 15, 10:05

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Aug 20, 11:50

Pre-Opening Session Prices9:00 am - 9:15 am

BSE

Oct 25, 09:15
58.55 0.80 (1.39%)
High 58.85
Low 58.55
Prev. Close 57.75
NSE - No shares traded

Financials

(Rs. Cr)
Quarterly JUN 2020 MAR 2020 DEC 2019 SEP 2019 JUN 2019
Sales
12 18 19 14 16
Other Income
0 0 0 0 0
Total Income
12 19 19 14 16
Total Expenditure
14 21 22 17 18
EBIT
-2 -2 -2 -3 -1
Interest
0 0 0 0 0
Tax
-- 12 -0 -2 1
Net Profit
-2 -15 -2 -1 -3

Historical Prices

On
Current Price %Gain / Loss
Open Price 28.23 58.55
107.4
High Price 28.43 58.55
105.94
Low Price 27.27 55.10
102.05
Close Price 27.98 57.75
106.4
Volume 2,474 4,544
83.67
On
Current Price %Gain / Loss
Open Price 27.75 57.90
108.65
High Price 28.54 58.00
103.22
Low Price 27.25 56.00
105.5
Close Price 27.83 57.55
106.79
Volume 17,501 6,940
-60.35
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 11930.40 33.90 0.28
SENSEX 40685.50 127.01 0.31
NIFTY BANK 24478.30 -5.85 -0.02
NIFTY IT 21523.60 110.10 0.51
S&P BSE Smallcap 15134.59 106.51 0.71
Index Price Change %Chg
Nasdaq (Oct 24) 11,548.28 42.27 0.37
DAX (Oct 23) 12,645.75 102.69 0.82
FTSE (Oct 23) 5,860.28 74.63 1.29
CAC (Oct 23) 4,909.64 58.26 1.20
SGX Nifty (Oct 24) 11,970.00 35.00 0.29

CORPORATE ACTION

Date Agenda
Sep 15, 2020 Quarterly Results
Jul 30, 2020 Audited Results
Jul 21, 2020 Audited Results
Mar 03, 2020 Others
Feb 14, 2020 Quarterly Results
Type Dividend% Ex-Dividend date
No Dividends Information is available for Brooks Laboratories
Ratio Announcement Date Ex-Bonus
No Bonus Information is available for Brooks Laboratories
Old FV New FV Ex-Split
No Splits Information is available for Brooks Laboratories
Ratio Premium Ex-Bonus
9:20 10 Feb 11, 2020
Date Agenda
Sep 28, 2020 -
Sep 25, 2019 -
Jul 20, 2019 -
Aug 10, 2018 -
Sep 28, 2017 -

Dividend Summary

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone September 2020 March 2020 December 2019 September 2019
Promoters 66.41 66.41 62.58 62.58
Pledged 0 0 0 0
FII/FPI 0 0 0 0
Total DII 5.3 5.21 7.21 7.38
Fin.Insts 0 0 0.05 0
Insurance Co 0 0 0 0
MF 0 0 0 0
Others DIIs 5.3 5.21 7.16 7.38
Others 28.28 28.38 30.21 30.04
Total 99.99 100 100 100

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Brooks Labs 56.35 -2.42 72.25 14.05 139.2 69.69 -24.38
Sun Pharma 484.35 -0.27 564.90 315.20 116211.79 12,531.93 3,211.14
Dr Reddys Labs 5015.90 -0.15 5514.65 2497.60 83399.01 11,850.40 2,937.70
Divis Labs 3067.25 -0.60 3388.00 1627.15 81425.85 5,310.57 1,372.71
Cipla 756.85 -0.07 829.00 356.75 61029.79 12,659.15 2,318.17

COMPANY OVERVIEW

Brooks Laboratories Limited (Brooks Laboratories) is a pharmaceutical contract research and manufacturing services company. It provides range of products catering to critical care segment in Parental Section, such as Beta Lactam, Cephalosporin and General Dry powder Injectables, Ampoules and Liquid vials, and Dry Syrups and Tablets. As of March 31, 2010, its product portfolio consist of 26 dry powder injections, 31 liquid injections, five tablets and two dry syrups. It manufactures a range of products on third party basis for companies, such as Zydus Cadila, Alembic, Intas, Wockhardt, Medley, Biochem, JB Chemical, PDPL and Sanat. Brooks Laboratories has a range of products catering to critical care segment in parental section, such as Beta Lactum, Cephalosporin, Carbapenems, General Dry powder Injectables and Liquid Injectables. Its Carbapenems products include Inj Ertapenem and Inj Meropenem. Its Liquid Injectables include Inj Nandrolone Decanoate, Inj Aceclofenac and Inj Midazolam.

COMPANY INFORMATION

  • Registered Office

  • Registrars

  • Management

    • Name

      Designation

    • Atul Ranchal

      Chairman

    • Rajesh Mahajan

      Managing Director

    • Rajnish Kumar Bedi

      Independent Director

    • Deepak Mahajan

      Independent Director

    • Sonia Gupta

      Independent Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Brooks Laboratories Ltd.

Brooks Labs is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 533543 and the NSE with an NSE Code of BROOKS.

Related Searches